All In Biotech

Drug Trial Radar · NCT02160041

BGJ398 for Patients With Tumors With FGFR Genetic Alterations

Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 6 - BGJ398 for Patients With Tumors With FGFR Genetic Alterations

Last checked: Nov 20, 2026Latest source record: Jun 18, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

84

Actual

Start

Jul 24, 2014

Primary completion

Apr 30, 2018

Study completion Apr 30, 2018

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Jun 10, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this signal seeking study was to determine whether treatment with BGJ398 demonstrates sufficient efficacy in select FGFR pathway-regulated solid tumors and/or hematologic malignancies to warrant further study.

Conditions

  • Solid Tumor
  • Hematologic Malignancies

Interventions

  • BGJ398Drug

    BGJ398 was dosed on a flat scale of 125 mg (e.g., 1 x 100 mg and 1 x 25 mg capsules) once daily for the first 21 days of the 28-day cycle (3 weeks on, 1 week off in a cycle). A complete treatment cycle is defined as 28 days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Benefit Rate (CBR) Associated With BGJ398 TreatmentTime frame: 16 weeks

Locations

56 sites in 1 country. Site status is shown where the registry gives one.

  • Alabama Oncology St. Vincent's Birmingham

    Birmingham, Alabama

  • North County Oncology Medical Clinic Inc

    Oceanside, California

  • San Francisco General Hospital San Francisco Gen Hosp (7)

    San Francisco, California

  • Rocky Mountain Cancer Centers Rocky Mountain Cancer Ctr (50)

    Greenwood Village, Colorado

  • Norwalk Hospital

    Norwalk, Connecticut

  • Florida Cancer Specialists Florida Cancer Specialists 36

    Fort Myers, Florida

  • University of Miami Sylvester Comprehensive Cancer

    Miami, Florida

  • NorthWest Georgia Oncology Centers NW Georgia Oncology

    Marietta, Georgia

  • Harbin Clinic Medical Oncology Clin. Res.

    Rome, Georgia

  • Illinois Cancer Specialists

    Arlington Heights, Illinois

  • Lurie Children's Hospital of Chicago Developmental Therapeutics

    Chicago, Illinois

  • Community Clinical Research Center

    Anderson, Indiana

  • Indiana University Indiana Univ. - Purdue Univ.

    Indianapolis, Indiana

  • Northern Indiana Cancer Research Consortium No. Indiana Cancer Res.

    South Bend, Indiana

  • University of Louisville / James Graham Brown Cancer Center SC

    Louisville, Kentucky

  • St. Agnes Hospital St. Agnes Hospital (2)

    Baltimore, Maryland

  • Southcoast Centers for Cancer Care

    Fairhaven, Massachusetts

  • Cancer and Hematology Centers of West Michigan Dept. of Oncology

    Grand Rapids, Michigan

  • Minnesota Oncology Hematology, P.A. Minnesota Oncology Hem (27)

    Minneapolis, Minnesota

  • Research Medical Center Research Med Center (2)

    Kansas City, Missouri

  • Billings Clinic Billings Clinic (8)

    Billings, Montana

  • Dartmouth Hitchcock Medical Center Dartmouth Hitchcock - Lebanon

    Bedford, New Hampshire

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey

  • New Mexico Cancer Center

    Albuquerque, New Mexico

  • Waverly Hematology Oncology

    Cary, North Carolina

  • University of N C at Chapel Hill Physician Office Building

    Chapel Hill, North Carolina

  • Duke University Medical Center Seeley G. Mudd Bldg.

    Durham, North Carolina

  • Wake Forest Baptist Health Hem & Onc Medical Center

    Winston-Salem, North Carolina

  • Sanford Hematology Oncology

    Fargo, North Dakota

  • Oncology Hematology Care Inc Oncology Hematology Care 2

    Cincinnati, Ohio

  • University Hospitals of Cleveland Seidman Cancer Center University Hospitals

    Cleveland, Ohio

  • Cleveland Clinic Foundation Taussig Cancer Institute

    Cleveland, Ohio

  • Bend Memorial Clinic Bend Mem. Clinic

    Bend, Oregon

  • Northwest Cancer Specialists Northwest Cancer

    Portland, Oregon

  • Lehigh Valley Health Network

    Allentown, Pennsylvania

  • Cancer Treatment Centers of America Eastern Regional Medical Center

    Philadelphia, Pennsylvania

  • University of Pittsburgh Cancer Institute Hillman Cancer Center (2)

    Pittsburgh, Pennsylvania

  • Rhode Island Hospital Rhode Island Hosp. (2)

    Providence, Rhode Island

  • Sanford University of South Dakota Medical Center Sanford Health

    Sioux Falls, South Dakota

  • Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology

    Chattanooga, Tennessee

Showing 40 of 56 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.